Gender Differences in the Prevalence and Development of Metabolic Syndrome in Chinese Population with Abdominal Obesity

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Xu, Shaoyong ^a   Gao, Bin ^a   Xing, Ying ^a   Ming, Jie ^a   Bao, Junxiang ^a   Zhang, Qiang ^b   Wan, Yi ^a   Ji, Qiuhe ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL OBESITY; ADULT; ARTICLE; CHINESE; DISEASE ACTIVITY; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; RISK ASSESSMENT; SEX DIFFERENCE; AGE; CHINA; COMPLICATION; MIDDLE AGED; NONPARAMETRIC TEST; SEXUAL DEVELOPMENT;

ADULT; AGE FACTORS; CHINA; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; PREVALENCE; SEX CHARACTERISTICS; STATISTICS, NONPARAMETRIC;

EID: 84886246970     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078270     Document Type: Article

References (46)

1. Alberti KG, Zimmet PZ, (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553. doi:10.1002/(SICI)1096-9136(199807)15:7. PubMed: 9686693.
2. Grundy SM, Brewer HB Jr., Cleeman JI, Smith SC Jr, Lenfant C, et al. (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 24: e13-e18. PubMed: 14766739.
3. Alberti KG, Zimmet P, Shaw J, (2006) Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23: 469-480. doi:10.1007/BF02706751. PubMed: 16681555.
4. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645. doi:10.1161/CIRCULATIONAHA.109.192644. PubMed: 19805654.
5. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, et al. (2010) The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56: 1113-1132. doi:10.1016/j.jacc.2010.05.034. PubMed: 20863953.
6. Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, et al. (2004) Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53: 2087-2094. doi:10.2337/diabetes.53.8.2087. PubMed: 15277390.
7. Xi B, Liang Y, He T, Reilly KH, Hu Y, et al. (2012) Secular trends in the prevalence of general and abdominal obesity among Chinese adults, 1993-2009. Obes Rev 13: 287-296. doi:10.1111/j.1467-789X.2011.00944.x. PubMed: 22034908.
8. Popkin BM, Adair LS, Ng SW, (2012) Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev 70: 3-21. doi:10.1111/j.1753-4887.2011.00456.x. PubMed: 22221213.
9. Correia F, Poínhos R, Freitas P, Pinhão S, Maia A, et al. (2006) [Prevalence of the metabolic syndrome: comparison between ATPIII and IDF criteria in a feminine population with severe obesity]. Acta Med Port 19: 289-293. PubMed: 17328845.
10. Lafortuna CL, Agosti F, De Col A, Pera F, Adorni F, et al. (2012) Prevalence of the metabolic syndrome and its components among obese men and women in Italy. Obes Facts 5: 127-137. doi:10.1159/000336700. PubMed: 22433624.
11. Mathieu P, Lemieux I, Després JP, (2010) Obesity, inflammation, and cardiovascular risk. Clin Pharmacol Ther 87: 407-416. doi:10.1038/clpt.2009.311. PubMed: 20200516.
12. Freemantle N, Holmes J, Hockey A, Kumar S, (2008) How strong is the association between abdominal obesity and the incidence of type 2 diabetes? Int J Clin Pract 62: 1391-1396. doi:10.1111/j.1742-1241.2008.01805.x. PubMed: 18557792.
13. Hu FB, Liu Y, Willett WC, (2011) Preventing chronic diseases by promoting healthy diet and lifestyle: public policy implications for China. Obes Rev 12: 552-559. doi:10.1111/j.1467-789X.2011.00863.x. PubMed: 21366840.
14. Shen J, Goyal A, Sperling L, (2012) The emerging epidemic of obesity, diabetes, and the metabolic syndrome in china. Cardiol. Res Pract: pp. 2012: 178675.
15. Pei WD, Sun YH, Lu B, Liu Q, Zhang CY, et al. (2007) Apolipoprotein B is associated with metabolic syndrome in Chinese families with familial combined hyperlipidemia, familial hypertriglyceridemia and familial hypercholesterolemia. Int J Cardiol 116: 194-200. doi:10.1016/j.ijcard.2006.03.045. PubMed: 16828905.
16. Lu B, Yang Y, Song X, Dong X, Zhang Z, et al. (2006) An evaluation of the International Diabetes Federation definition of metabolic syndrome in Chinese patients older than 30 years and diagnosed with type 2 diabetes mellitus. Metabolism 55: 1088-1096. doi:10.1016/j.metabol.2006.04.003. PubMed: 16839846.
17. Li ZY, Xu GB, Xia TA, (2006) Prevalence rate of metabolic syndrome and dyslipidemia in a large professional population in Beijing. Atherosclerosis 184: 188-192. doi:10.1016/j.atherosclerosis.2005.03.033. PubMed: 15927187.
18. Lao XQ, Thomas GN, Jiang CQ, Zhang WS, Yin P, et al. (2006) Association of the metabolic syndrome with vascular disease in an older Chinese population: Guangzhou Biobank Cohort Study. J Endocrinol Invest 29: 989-996. PubMed: 17259796.
19. Feng Y, Hong X, Li Z, Zhang W, Jin D, et al. (2006) Prevalence of metabolic syndrome and its relation to body composition in a Chinese rural population. Obesity (Silver Spring) 14: 2089-2098. doi:10.1038/oby.2006.244.
20. Ko GT, Cockram CS, Chow CC, Yeung V, Chan WB, et al. (2005) High prevalence of metabolic syndrome in Hong Kong Chinese--comparison of three diagnostic criteria. Diabetes Res Clin Pract 69: 160-168. doi:10.1016/j.diabres.2004.11.015. PubMed: 16005365.
21. Fan JG, Zhu J, Li XJ, Chen L, Lu YS, et al. (2005) Fatty liver and the metabolic syndrome among Shanghai adults. J Gastroenterol Hepatol 20: 1825-1832. doi:10.1111/j.1440-1746.2005.04058.x. PubMed: 16336439.
22. Grundy SM, (2008) Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 28: 629-636. doi:10.1161/ATVBAHA.107.151092. PubMed: 18174459.
23. Hwang LC, Bai CH, Chen CJ, Chien KL, (2007) Gender difference on the development of metabolic syndrome: a population-based study in Taiwan. Eur J Epidemiol 22: 899-906. doi:10.1007/s10654-007-9183-5. PubMed: 17926136.
24. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, et al. (2003) Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108: 414-419. doi:10.1161/01.CIR.0000080897.52664.94. PubMed: 12860911.
25. Kuk JL, Ardern CI, (2010) Age and sex differences in the clustering of metabolic syndrome factors: association with mortality risk. Diabetes Care 33: 2457-2461. doi:10.2337/dc10-0942. PubMed: 20699434.
26. Ervin RB, (2009) Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Report: 1-7.
27. Yang W, Lu J, Weng J, Jia W, Ji L, et al. (2010) Prevalence of diabetes among men and women in China. N Engl J Med 362: 1090-1101. doi:10.1056/NEJMoa0908292. PubMed: 20335585.
28. Hou X, Lu J, Weng J, Ji L, Shan Z, et al. (2013) Impact of waist circumference and body mass index on risk of cardiometabolic disorder and cardiovascular disease in Chinese adults: a national diabetes and metabolic disorders survey. PLOS ONE 8: e57319. doi:10.1371/journal.pone.0057319. PubMed: 23520466.
29. Gao Y, Chen G, Tian H, Lin L, Lu J, et al. (2013) Prevalence of hypertension in china: a cross-sectional study. PLOS ONE 8: e65938. doi:10.1371/journal.pone.0065938. PubMed: 23776574.
30. Yang ZJ, Liu J, Ge JP, Chen L, Zhao ZG, et al. (2012) Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China National Diabetes and Metabolic Disorders Study. Eur Heart J 33: 213-220. doi:10.1093/eurheartj/ehr205. PubMed: 21719451.
31. Yang W, Xiao J, Yang Z, Ji L, Jia W, et al. (2012) Serum lipids and lipoproteins in Chinese men and women. Circulation 125: 2212-2221. doi:10.1161/CIRCULATIONAHA.111.065904. PubMed: 22492668.
32. Joint Committee for Developing Chinese (2007) Guidelines on Prevention and Treatment of Dyslipidemia in Adults Chinese Guidelines on prevention and treatment of dyslipidemia in adults. Chin J Cardi 35: 390-419. (in Chinese).
33. National Bureau of Statistics of China. China (2006) Beijing: China: Statistics Press; (Accessed February 26(2010). Available http://www.stats.gov.cn/tjsj/ndsj/2006/indexeh.htm.
34. Gu D, Reynolds K, Wu X, Chen J, Duan X, et al. (2005) Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365: 1398-1405. doi:10.1016/S0140-6736(05)66375-1. PubMed: 15836888.
35. Safar ME, Lange C, Blacher J, Eschwège E, Tichet J, et al. (2011) Mean and yearly changes in blood pressure with age in the metabolic syndrome: the DESIR study. Hypertens Res 34: 91-97. doi:10.1038/hr.2010.180. PubMed: 20927113.
36. Alexander CM, Landsman PB, Grundy SM, (2008) The influence of age and body mass index on the metabolic syndrome and its components. Diabetes Obes Metab 10: 246-250. doi:10.1111/j.1463-1326.2006.00695.x. PubMed: 18269640.
37. Gause-Nilsson I, Gherman S, Kumar Dey D, Kennerfalk A, Steen B, (2006) Prevalence of metabolic syndrome in an elderly Swedish population. Acta Diabetol 43: 120-126. doi:10.1007/s00592-006-0226-2. PubMed: 17211562.
38. Saukkonen T, Jokelainen J, Timonen M, Cederberg H, Laakso M, et al. (2012) Prevalence of metabolic syndrome components among the elderly using three different definitions: a cohort study in Finland. Scand J Prim Health Care 30: 29-34. doi:10.3109/02813432.2012.654192. PubMed: 22324547.
39. Liu LS, (2011) [2010 Chinese guidelines for the management of hypertension]. Zhonghua Xin Xue Guan Bing Za Zhi 39: 579-615. PubMed: 22088239.
40. Franco OH, Massaro JM, Civil J, Cobain MR, O'Malley B, et al. (2009) Trajectories of entering the metabolic syndrome: the framingham heart study. Circulation 120: 1943-1950. doi:10.1161/CIRCULATIONAHA.109.855817. PubMed: 19884471.
41. Martelli V, Valisella S, Moscatiello S, Matteucci C, Lantadilla C, et al. (2011) Prevalence of Sexual Dysfunction among Postmenopausal Women with and without Metabolic Syndrome. J Sex Med, 9: 434-41. PubMed: 22023878.
42. Shakir YA, Samsioe G, Nyberg P, Lidfeldt J, Nerbrand C, et al. (2007) Do sex hormones influence features of the metabolic syndrome in middle-aged women? A population-based study of Swedish women: the Women's Health in the Lund Area (WHILA) Study. Fertil Steril 88: 163-171. doi:10.1016/j.fertnstert.2006.11.111. PubMed: 17383645.
43. Cui R, Iso H, Yamagishi K, Saito I, Kokubo Y, et al. (2012) High serum total cholesterol levels is a risk factor of ischemic stroke for general Japanese population: the JPHC study. Atherosclerosis 221: 565-569. doi:10.1016/j.atherosclerosis.2012.01.013. PubMed: 22341595.
44. Benfante R, Yano K, Hwang LJ, Curb JD, Kagan A, et al. (1994) Elevated serum cholesterol is a risk factor for both coronary heart disease and thromboembolic stroke in Hawaiian Japanese men. Implications of shared risk. Stroke 25: 814-820. doi:10.1161/01.STR.25.4.814. PubMed: 8160226.
45. Benfante R, Reed D, (1990) Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? JAMA 263: 393-396. doi:10.1001/jama.1990.03440030080025. PubMed: 2294305.
46. Iso H, Jacobs DR Jr., Wentworth D, Neaton JD, Cohen JD, (1989) Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med 320: 904-910. doi:10.1056/NEJM198904063201405. PubMed: 2619783.